AzadR,SainS,SharmaYR,MahajanD, 2012.Comparison of intravitreal bevacizumab, intravitreal triamcinolone acetonide, and macular grid augmentation in refractory diffuse diabetic macular edema: A prospective, randomized study,Oman J Ophthalmol 5 166 -
BakriSJ,PulidoJS,McCannelCA,HodgeDO,DiehlN,HillemeierJ, 2009.Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab,Eye 23 181 -5
BenzMS,AlbiniTA,HolzER, 2006.Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide,Ophthalmology 113 1174 -78
BoonCJ,CramaN,KleveringBJ,van KuijkFJ,HoyngCB, 2008.Reflux after intravitreal injection of bevacizumab,Ophthalmology 115 1270 -
CacciamaniA,OddoneF,ParravanoM,ScarinciF,Di NicolaM,LofocoG, 2013.Intravitreal injection of bevacizumab: Changes in intraocular pressure related to ocular axial length,Jpn J Ophthalmol 57 63 -7
CioboataM,AnghelieA,ChiotanC,LioraR,SerbanR,CornăcelC, 2014.Benefits of anterior chamber paracentesis in the management of glaucomatous emergencies,J Med Life 7 5 -6
DehghaniA,JafariH,Shoeibi N, 2014.Short-term intraocular pressure changes after intravitreal bevacizumab injection,Reviews in Clinical Medicine 1 93 -6
DingJ,WongTY, 2012.Current epidemiology of diabetic retinopathy and diabetic macular edema,Current diabetes reports 12 346 -54
DwingerMC,Pieper-BodeewesI,EterN,HolzFG, 2005.Variations in intraocular pressure (IOP) and necessity for paracentesis following intravitreal triamcinolone injection,Klin Monbl Augenheilkd 222 638 -42
FalavarjaniKG,NguyenQD, 2013.Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature,Eye 27 787 -94
FalkensteinIA,ChengL,FreemanWR, 2007.Changes of intraocular pressure after intravitreal injection of bevacizumab (Avastin),Retina 27 1044 -7
FarhoodQK,TwfeeqSM, 2014.Short-term intraocular pressure changes after intravitreal injection of bevacizumab in diabetic retinopathy patients,Clinical Ophthalmology (Auckland, NZ) 8 599 -604
FossAJ,ScottLJ,RogersCA,ReevesBC,GhanchiF,GibsonJ, 2015.Changes in intraocular pressure in study and fellow eyes in the IVAN trial,Br J Ophthalmol -
FurlaniBA,MeyerCH,RodriguesEB,MaiaM,FarahME,PenhaFM, 2007.Emerging pharmacotherapies for diabetic macular edema,Expert opinion on emerging drugs 12 591 -603
GismondiM,SalatiC,SalvetatML,ZeppieriM,BrusiniP, 2009.Shortterm effect of intravitreal injection of Ranibizumab (Lucentis) on intraocular pressure,J Glaucoma 18 658 -61
GoktasA,GoktasS,AtasM, 2013.Short-term impact of intravitreal ranibizumab injection on axial ocular dimension and intraocular pressure,Cutan Ocul Toxicol 32 23 -6
HoangQV,TsuangAJ,GelmanR,MendoncaLS,Della TorreKE,JungJJ, 2013.Clinical predictors of sustained intraocular pressure elevation due to intravitreal anti-vascular endothelial growth factor therapy,Retina 33 179 -87
HollandsH,WongJ,BruenR,CampbellRJ,SharmaS,GaleJ, 2007.Short-term intraocular pressure changes after intravitreal injection of bevacizumab,Can J Ophthalmol /Journal Canadien d' Ophtalmologie 42 807 -11
KimJE,MantravadiAV,HurEY,CovertDJ, 2008.Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents,Am J Ophthalmol 146 930 -4
KimGN,HanYS,ChungIY,SeoSW,ParkJM,YooJM, 2013.Effect of Dorzolamide/Timolol or Brinzolamide/Timolol prophylaxis on intravitreal anti-VEGF injection-induced intraocular hypertension,In Seminars in ophthalmology 28 61 -67
KotliarK,MaierM,BauerS,FeuchtN,LohmannC,LanzlI, 2007.Effect of intravitreal injections and volume changes on intraocular pressure: clinical results and biomechanical model,Acta Ophthalmologica Scandinavica 85 77781 -
LeeJW,ParkH,ChoiJH,LeeHJ,MoonSW,KangJH, 2016.Short-term changes of intraocular pressure and ocular perfusion pressure after intravitreal injection of bevacizumab or ranibizumab,BMC ophthalmology 16 1 -
Lemos-ReisR,Moreira-GonçalvesN,MeloAB,CarneiroÂM,Falcão-ReisFM, 2014.Immediate effect of intravitreal injection of bevacizumab on intraocular pressure. Clinical ophthalmology (Auckland, 8 1383 -
MareyHM,EllakwaAF, 2011.Intravitreal bevacizumab alone or combined with triamcinolone acetonide as the primary treatment for diabetic macular edema,Clin Ophthalmol [Internet] 5 1011 -6
MojicaG,HariprasadSM,JagerRD,MielerWF, 2008.Short-term intraocular pressure trends following intravitreal injections of ranibizumab (Lucentis) for the treatment of wet age-related macular degeneration,Br J Ophthalmol 92 584 -
MathaloneN,Arodi-GolanA,SarS,WolfsonY,ShalemM,LaviI, 2012.Sustained elevation of intraocular pressure after intravitreal injections of bevacizumab in eyes with neovascular age-related macular degeneration,Ger J Ophthalmol 250 1435 -40
Popa-CherecheanuA,IancuRC,SchmettererL,PirvulescuR,CoviltirV.,IntraocularPressure, 2017.Refractive Changes after Phacoemulsification and Trabeculectomy for Open-Angle Glaucoma,J Ophthalmol 1203269 -
ReadSA,CollinsMJ,Annis-BrownT,HaywardNM,LillymanK,SherwinD,StockallP., 2011.The short-term influence of elevated intraocular pressure on axial length,Ophthalmic Physiol Opt 31 398 -403
SoheilianM,KarimiS,MontahaeT,NikkhahH,MosaviSA, 2017.Effects of intravitreal injection of bevacizumab with or without anterior chamber paracentesis on intraocular pressure and peripapillary retinal nerve fiber layer thickness: A prospective study,Graefes Arch Clin Exp Ophthalmol 255 1705 -12